zwischen 15,20 und 15,30 wirds kribbelig
Anzeige
Meldung des Tages: Warum diese neue Germanium-News mehr bedeutet als eine klassische Explorationsmeldung
Neuester,
zuletzt geles. Beitrag
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter
... 26 27 28 30 31 32 ...
Antworten | Hot-Stocks-Forum Übersicht
Zurück
Weiter ... 26 27 28 30 31 32 ...
rebound eingeläutet!??
Beiträge:
1.458
Zugriffe: 250.277 / Heute: 2
Zugriffe: 250.277 / Heute: 2
|
Werbung
Entdecke die beliebtesten ETFs von Xtrackers
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +84,90%
Xtrackers Spain UCITS ETF 1D
Perf. 12M: +57,05%
Xtrackers Spain UCITS ETF 1C
Perf. 12M: +56,92%
Xtrackers ATX UCITS ETF 1C
Perf. 12M: +53,93%
Xtrackers CSI500 Swap UCITS ETF 1C
Perf. 12M: +53,84%
warum weiß das jemand? echt schade war nur bei cannabis science und grow life dabei
spätestens bei 10,00 bin ich raus;-)))))) kleiner scherz
seit wann machen wir den Kurs bei den Amis...
wir dürfen froh sein das wir die überhaupt handeln können
wir dürfen froh sein das wir die überhaupt handeln können
... an die Tulpenhausse, irgendwann werden für die besten Pflanzen utopische Kurse bezahlt. P.S.: Ich rauche nicht.
Hemp zum Beispiel kann man nur im Amiland handeln
Was ja auch kein Nachteil ist, oft ordert man in USA billiger
Was ja auch kein Nachteil ist, oft ordert man in USA billiger
Aus den selben Grund warum heute Cannabis Science auch so steigt....
Siehe Posting 677 von User Andrew
Oder dies hier.....
Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law
COLORADO SPRINGS, Colo., Feb. 4, 2014 /PRNewswire/ -- Cannabis Science, Inc. CBIS +17.23% , a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is pleased that the U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients.
Last week the U.S. House of Representatives approved the "farm bill" that contains a provision for certain cultivation of industrial hemp for research in a number of U.S. states. The Senate is expected to approve the measure as soon as today, and President Obama has declared that he will sign the bill into law, changing the legal landscape for the entire hemp industry.
"As hemp and cannabis both come from the same plant, federal movement on liberalization of hemp cultivation and research will positively impact Cannabis Science's opportunities for pharmaceutical research and development of cannabis and cannabinoid-based pharmaceutical products for patients. The House has approved the bill, and the Senate is expected vote in favor of it today or tomorrow, with near certain approval from the President. The Company is formulating its strategy for this regulatory opening to more quickly bring pharmaceutical products to market for the benefit of patients in need," said Chad S. Johnson, Chief Operating Officer and General Counsel of Endocan Corporation.
About Cannabis Science, Inc. Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions.
Forward Looking Statements This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Science, Inc.
Siehe Posting 677 von User Andrew
Oder dies hier.....
Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law
COLORADO SPRINGS, Colo., Feb. 4, 2014 /PRNewswire/ -- Cannabis Science, Inc. CBIS +17.23% , a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is pleased that the U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients.
Last week the U.S. House of Representatives approved the "farm bill" that contains a provision for certain cultivation of industrial hemp for research in a number of U.S. states. The Senate is expected to approve the measure as soon as today, and President Obama has declared that he will sign the bill into law, changing the legal landscape for the entire hemp industry.
"As hemp and cannabis both come from the same plant, federal movement on liberalization of hemp cultivation and research will positively impact Cannabis Science's opportunities for pharmaceutical research and development of cannabis and cannabinoid-based pharmaceutical products for patients. The House has approved the bill, and the Senate is expected vote in favor of it today or tomorrow, with near certain approval from the President. The Company is formulating its strategy for this regulatory opening to more quickly bring pharmaceutical products to market for the benefit of patients in need," said Chad S. Johnson, Chief Operating Officer and General Counsel of Endocan Corporation.
About Cannabis Science, Inc. Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions.
Forward Looking Statements This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Science, Inc.
... , bin gestern auch noch schnell bei HEMP eingestiegen.
das mit den OTC Werten macht richtig spass.
Vor wenigen Wochen bin ich angefangen ein wenig zu zocken.
Nur ein wenig Spielgeld.
Ich muss sagen das auch Kleinvieh Mist macht.
Bis jetzt hat es sich gelohnt.
Im Moment bin ich bei vier Werten drin ( thema grüne Pflanze )
Bei Hemp bin ich Gestern erstmal ausgestiegen.
150% in fast zwei Tagen!!
Ich hoffe darauf, dass die mal wieder tiefen kommen.
Sonst bin ich noch in "AEGY" "SKTO""MJNA"
und noch eine andere! Die fällt mir gerade nicht ein.
Vor wenigen Wochen bin ich angefangen ein wenig zu zocken.
Nur ein wenig Spielgeld.
Ich muss sagen das auch Kleinvieh Mist macht.
Bis jetzt hat es sich gelohnt.
Im Moment bin ich bei vier Werten drin ( thema grüne Pflanze )
Bei Hemp bin ich Gestern erstmal ausgestiegen.
150% in fast zwei Tagen!!
Ich hoffe darauf, dass die mal wieder tiefen kommen.
Sonst bin ich noch in "AEGY" "SKTO""MJNA"
und noch eine andere! Die fällt mir gerade nicht ein.
Also 0,1625€. Mal sehen ob es sich bei uns hält und die Ammis nachziehen!
Sind die Ammis bei uns unterwegs?!
oder wie kam dann der Kurs zu 0,23$ zu Stande?
... die News kamen gestern erst spät am Nachmittag, deshalb heute wirklich Powerday!
...für heute genügend Cash besorgt! Dann geht's wirklich ab. Bin gestern sehr euphorisch gewesen... Heute etwas betrübt, ob der Taxen... Aber es ist ja noch etwas Zeit. Erhoffe mir Anfangstaxen um die 0,26$ bis 0,32$!
Aber nur minimal. Jetzt zeigt sich was wir zu erwarten haben!
... hat schon oft getäuscht.
Ich persönlich bin heute mit + 100 % schon mal gut bedient, bleibe aber weiter drin.
Ich persönlich bin heute mit + 100 % schon mal gut bedient, bleibe aber weiter drin.
Hast du einen Link für den PreMarket? Außer otcmarkets.com...
... Nasdaq Pre müsste funzen, google mal.
Bisher keine Trades. Nur gestern nachbörslich 3 Millionen zu unter 0,20$... Hmm nicht so dolle. Bin echt gespannt wohin das heute führt!
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem Cannabis Science Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 19 | AK 47;TOP 44;SKUNK-1000% tenbagger....... | Knallpatrone23 | S010711 | 25.04.21 03:24 | ||
7 | 1.457 | rebound eingeläutet!?? | ARTNER514 | Fachstahl | 25.04.21 02:01 | |
| 2 | 785 | Cannabis Science - kurz vor dem Durchbruch? | Mr.Cashh | famherzig | 25.04.21 01:21 | |
| 16 | 3.518 | CANNABIS SCIENCE - Revolution oder Verblendung ? | Brokerface030 | Reecco | 25.04.21 01:13 | |
| 151 | THC Therapeutics in einer Woche über + 350% | Temesta | Mr.Cashh | 24.04.21 23:45 |